Main index: 211,943 Documents
BookBoxo.com - outstanding document search machine

GRIBBENHOP PHARMACEUTICALS

Press Release License And Supply Agreement Bio3 Research Xediton Pharmaceuticals
  • Size: 49 KB
  • Author: none
  • Created: Wed Nov 13 15:16:31 2013
  • Total Pages: 2

Microsoft Word - Press Release License and Supply Agreement Bio3 Research - Xediton Pharmaceuticals.doc Bio 3 ResearchBiotechnology Bioelectronics BiomedicineBio3 Research S r l Milano Italy Appoints Xediton Pharmaceuticals asExclusive Licensee of the Dietary Supplement Biocysan in CanadaMilano Italy November 12th 2013 Bio3 Research S r l announced today that the company hasgranted to Xediton Phar...

biocysan.com/pdf/Press Release License and Supply Agree...maceuticals.pdf
05 10 Cs Royal Pharmaceuticals Metastorm Doc2
  • Size: 232 KB
  • Author: none
  • Created: Mon Jun 14 11:23:11 2010
  • Total Pages: 5

Microsoft Word - 05-10-CS-Royal Pharmaceuticals-Metastorm.doc.doc BPTrends Case Study May 2010 Royal Pharmaceuticals Case StudyRoyal Pharmaceuticals Case StudyPaul HarmonThe Royal Pharmaceutical Society of Great Britain RPSGB is a professional body forpharmacists and the regulatory body for pharmacists and pharmacy technicians in EnglandScotland and Wales The RPSGB investigates complaints and in s...

businessprocesstrends.com/publicationfiles/05-10-CS-Roy...astorm.doc2.pdf
New Haven Pharmaceuticals Files Durlaza Nda
  • Size: 212 KB
  • Author: none
  • Created: Thu Sep 11 21:54:49 2014
  • Total Pages: 1

New Haven Pharmaceuticals Files DURLAZA New Drug Application Specialty Pharmaceuticals company announces submission of New DrugApplication to the FDANew Haven CT PRWEB September 11 2014New Haven Pharmaceuticals Inc the Company a privately held specialty Pharmaceuticals company todayannounced the submission of a New Drug Application NDA to the US Food and Drug Administration FDA onSeptember 5 2014 ...

newhavenpharma.com/New-Haven-Pharmaceuticals-Files-DURL...DURLAZA-NDA.pdf
Domperidone Maleate
  • Size: 155 KB
  • Author: none
  • Created: Tue Jun 26 08:58:39 2015
  • Total Pages: 2

Domperidone Maleate manufacturers in India, cas. No. 99497-03-7, Active Pharmaceuticals Ingredients Domperidone Maleate, API Manufacturer, Domperidone Maleatebuy, sell, import, export, Domperidone Maleate manufacturers in India cas No 99497-03-7 Active Pharmaceuticals Ingredients Domperidone Maleate API Manufacturer Domperidone Maleatebuy sell import exportmanufacturing export Domperidone Maleate ...

tajapi.com/Pharmaceuticals API List_2011.pdf/Domperidon...one Maleate.pdf
Bayberry Pharmaceuticals Pvt Ltd
  • Size: 1042 KB
  • Author: none
  • Created: Tue Jan 27 03:00:19 2015
  • Total Pages: 20

Bayberry Pharmaceuticals Pvt. Ltd., Pune - Manufacturer & Exporter of Antibiotics Tablets & Capsules, Antibiotic Syrups & Suspensions, Anti-Inflamatory Analgaesic 91-8377801477Bayberry Pharmaceuticals PvtLtdwww bayberrypharma co inWe are a prominent Manufacturer and Exporter ofAntibiotics Tablets Capsules Antibiotics SyrupsSuspensions etc These products are extremelydemanded in market and widely a...

bayberrypharma.co.in/bayberry-pharmaceuticals-pvt-ltd.p...als-pvt-ltd.pdf
Testosterone
  • Size: 151 KB
  • Author: none
  • Created: Tue Jun 26 08:58:39 2015
  • Total Pages: 3

Testosterone manufacturers in India, cas. No. 58-22-0, Active Pharmaceuticals Ingredients Testosterone, API Manufacturer, Testosteronebuy, sell, import, export, Testosterone manufacturers in India cas No 58-22-0 Active Pharmaceuticals Ingredients Testosterone API Manufacturer Testosteronebuy sell import export manufacturing exportTestosterone trading India Testosterone API Manufacturer India Pharm...

tajapi.com/Pharmaceuticals API List_3_2011.pdf/Testoste...estosterone.pdf
Glenmark Pharmaceuticals Q2
  • Size: 92 KB
  • Author: none
  • Created: Wed Oct 27 15:03:06 2010
  • Total Pages: 3

Microsoft Word - Q2FY11-Glenmark Pharmaceuticals-Result-Update-Fortune-271010.doc India Equity ResearchFortuneBuy October 27 2010Glenmark PharmaQ2FY11 Result UpdateSector Outlook Positive PharmaceuticalsTarget Price Rs345 On a recovery path Recommend BuyCMP Rs312 Glenmark Pharmaceuticals GPL results were in line with our estimatesRevenues were up by 22 7 YoY to Rs7 2 bn vs our estimate of Rs7 bnUp...

72.41.105.187/Reports/Results/Glenmark Pharmaceuticals-...euticals-Q2.pdf
Half Year Report 31 7 13
  • Size: 366 KB
  • Author: none
  • Created: Tue Jul 30 09:32:29 2013
  • Total Pages: 44

Medicis ValeantCB-03-01 NCE Steroid ester Licensed outAlopecia androgen antagonist worldwideMedicis ValeantLMW Heparin MMX BiologicInduction of remission in UCMaintenance of remission for UCCB-01-16 Opioids antagonistOpioid-Induced Constipation2 Cosmo Pharmaceuticals Half-Year Report 2013 Cosmo s pipelineTable of contentsCosmo s pipeline 2Highlights 4Cosmo at a glance 5Key figures 5Letter to Share

cosmopharmaceuticals.com/~/media/Files/C/Cosmo-Pharmace...ort-31-7-13.pdf
Productinfo Fr
  • Size: 237 KB
  • Author: none
  • Created: Thu May 1 13:28:38 2014
  • Total Pages: 15

E R GlaxoSmithKline Pharmaceuticals s a n v - Site Apollo - Avenue Pascal 2 4 6 - 1300 Wavre LISTE DE PRIX SERETIDENom Nombres de doses Prix publicSeretide Diskus 100 50 g 60 doses 33 24Seretide Diskus 250 50 g 60 doses 41 82Seretide Diskus 500 50 g 60 doses 54 27Seretide A rosol 50 25 g 120 doses 33 24Seretide A rosol 125 25 g 120 doses 41 82Seretide A rosol 250 25 g 120 doses 54 27Veuillez signa...

a4mstatic.actito.be/media/MediQuality/gsk/Seretide/prod...ductinfo_fr.pdf
Provectus Completes Patient Accrual In Phase 2c
  • Size: 43 KB
  • Author: none
  • Created: Tue May 24 09:23:11 2011
  • Total Pages: 1

Provectus Pharmaceuticals Receives Patent Allowances in Europe and China Contact Porter LeVay Rose IncProvectus Pharmaceuticals Inc Marlon Nurse DM VP Investor RelationsPeter R Culpepper CFO Bill Gordon SVP Media RelationsPhone 866-594-5999 30 Phone 212-564-4700FOR IMMEDIATE RELEASEPROVECTUS Pharmaceuticals COMPLETES PATIENT ACCRUAL IN PHASE 2C CLINICAL TRIALOF PH-10 FOR PSORIASIS- Multi-Center Ra...

plrinvest.com/images/Provectus_Completes_Patient_Accrua...In_Phase_2C.pdf
P061020
  • Size: 57 KB
  • Author: none
  • Created: Fri Oct 20 12:37:31 2006
  • Total Pages: 4

Neuren Pharmaceuticals Limited Neuren research shows cancer regression in preclinical modelKey pointsTwo Trefoil Factors TFFs have been identified as critical for cancer cell survivalInhibition of TFFs using antibodies resulted in almost complete regression ofbreast cancer in animal modelsInhibition of TFFs has applicability to a range of cancers including colon lung andprostate cancerPatent appli...

202.66.146.82/listco/au/neuren/pr...ess/p061020.pdf
Divalproex Sodium
  • Size: 287 KB
  • Author: none
  • Created: Tue Jun 26 08:58:39 2015
  • Total Pages: 3

Divalproex Sodium manufacturers in India, cas. No. 76584-70-8, Active Pharmaceuticals Ingredients Divalproex Sodium, API Manufacturer, Divalproex Sodiumbuy, sell, import, export Divalproex Sodium manufacturers in India cas No 76584-70-8 Active Pharmaceuticals Ingredients Divalproex Sodium API Manufacturer Divalproex Sodiumbuy sell import export manufacturingexport Divalproex Sodium trading India D...

tajapi.com/Pdf_1_2011/Divalp...roex Sodium.pdf
Pediatric Asthma 06 19 2007
  • Size: 34 KB
  • Author: none
  • Created: Thu Aug 14 12:40:51 2008
  • Total Pages: 6

Best Pharmaceuticals for Children Act (BPCA) - Pediatric Asthma Working Group Conference Call Best Pharmaceuticals for Children Act BPCAPediatric Asthma Working Group Conference CallJune 19 200711 30 a m 12 30 p m ETParticipantsJoe Carcillo M DChristopher Carroll M DDenise Dougherty Ph DPeyton Eggleston M DMatthew Fenton Ph DErwin Gelfand M DTheresa Guilbert M DJan LeaheyDonald Mattison M DChristo...

bpca.nichd.nih.gov/collaborativeefforts/Documents/pedia..._06-19-2007.pdf
1210
  • Size: 131 KB
  • Author: none
  • Created: Tue Oct 28 19:47:01 2003
  • Total Pages: 16

Prices And Availability Of Pharmaceuticals: Evidence From Nine Countries Nine Co untr ie sPrices And Availability OfPharmaceuticals EvidenceFrom Nine CountriesThe U S market structure with its higher prices for on-patent productsand strong generic competition appears more favorable to innovationthan markets elsewhereby Patricia M Danzon and Michael F FurukawaABSTRACT This study compares average pr...

d1c25a6gwz7q5e.cloudfront.net/...papers/1210.pdf
27 Full
  • Size: 522 KB
  • Author: none
  • Created: Fri Oct 12 16:20:54 2007
  • Total Pages: 5

Safety Assessment of Biotechnology-Derived Pharmaceuticals ICH and BeyondMERCEDES A SERABIAN AND ANNE M PILAROU S Food and Drug Administration Center for Biologics Evaluation and ResearchOffice of Therapeutics Research and Review Rockville Maryland 20852ABSTRACTMany scientific discussions especially in the past 8 yr have focused on definition of criteria for the optimal assessment of thepreclinica...

tpx.sagepub.com/content/2...7/1/27.full.pdf
0201
  • Size: 140 KB
  • Author: none
  • Created: Tue Oct 7 14:29:31 2008
  • Total Pages: 8

EnviroInfo 2007: Data-Availability of Pharmaceuticals Detected in Water: An Evaluation Study by Order Theory (METEOR) EnviroInfo 2007 WarschauEnvironmental Informatics and Systems ResearchCopyright Shaker Verlag Aachen 2007 ISBN 978-3-8322-6397-3Data-Availability of Pharmaceuticals Detected in WaterAn Evaluation Study by Order Theory METEORKristina Voigt1 Rainer Br ggemann2AbstractThe topic of pha...

enviroinfo.eu/sites/default/files/pdfs/...vol117/0201.pdf
Aegr News 2009 11 16 General Releases
  • Size: 17 KB
  • Author: none
  • Created: none
  • Total Pages: 2

Aegerion Pharmaceuticals Announces Additional Lomitapide AEGR-733 Phase III Data Demonstrates Significant Lowering of LDL Cholesterol with Promising Safety ProfileResults Will Be Presented Today At AHA Conference in Orlando FloridaBRIDGEWATER NJNovember 16 2009 Aegerion Pharmaceuticals Inc a biopharmaceutical company focused on the treatment of cardiovascular and metabolicdisease today announced a...

files.shareholder.com/downloads/AEGR/0x0x411091/4c77f2f...al_Releases.pdf
F3642e4c 8e44 4b6b Ba7a 4b38c3284f65 Pdf Noexit True
  • Size: 1522 KB
  • Author: none
  • Created: Mon Sep 9 07:29:11 2013
  • Total Pages: 28

VALEANT Pharmaceuticals INTERNATIONAL, INC. VALEANT PHARMACEUTICALSINTERNATIONAL INCFORM 8-KCurrent report filingFiled 09 09 13 for the Period Ending 09 09 13Telephone 514-744-6792CIK 0000885590Symbol VRXSIC Code 2834 - Pharmaceutical PreparationsIndustry Biotechnology DrugsSector HealthcareFiscal Year 12 31http www edgar-online comCopyright 2013 EDGAR Online Inc All Rights ReservedDistribution an...

valeant.q4cdn.com/f3642e4c-8e44-4b6b-ba7a-4b38c3284f65....pdf?noexit=true
Servier Group Egis Press Release 07112013
  • Size: 328 KB
  • Author: none
  • Created: Fri Nov 8 09:56:44 2013
  • Total Pages: 2

Servier s Voluntary Public Offer for the outstanding shares in Egis Pharmaceuticals plc has closed Valid acceptances total in excess of 3 543 617 shares giving Servier ownership and control of over 96 43 ofEgisSuresnes France November 7 2013 Arts et Techniques du Progr s ATP a wholly owned subsidiaryof the Servier Group announces that its Voluntary Public Offer the Offer for all outstanding shares...

coversyl.com/sites/default/files/Servier Group_Egis_pre...se_07112013.pdf
131107sntslicenseagreement Ger
  • Size: 112 KB
  • Author: none
  • Created: Thu Nov 7 17:32:44 2013
  • Total Pages: 2

Cosmo gibt bekannt dass der Lizenzvertrag mit Santarus im Fall des Vollzugs der angek ndigten Fusion zwischen Santarus undSalix angepasst wirdLainate Italien 8 November 2013 Cosmo Pharmaceuticals SIX COPN weistim Zusammenhang mit der am 7 November 2013 bekanntgewordenen Fusionzwischen Salix und Santarus NASDAQ SNTS auf eine zus tzliche Vereinbarungmit Cosmo hin Demnach ist Cosmo mit Salix und Sant...

cosmopharmaceuticals.com/~/media/Files/C/Cosmo-Pharmace...reement_GER.pdf
Epidiolex 10 14 14
  • Size: 521 KB
  • Author: none
  • Created: Tue Oct 14 10:38:10 2014
  • Total Pages: 7

GW Pharmaceuticals Announces New Physician Reports of Epidiolex Treatment Effect in Children and Young Adults with Treatment-Resistant Epilepsy- Physician reports show signals of efficacy and safety consistent with previously disclosed data as wellas maintenance of clinical effect beyond 12 weeks and high retention rate -- Data to be presented at R D Day today commencing at 10 00 a m ET 15 00 BST ...

enewsletters.biospace.com/images/pdf/Epidiolex_10.14.14...ex_10.14.14.pdf
Attend Urological Conf
  • Size: 136 KB
  • Author: none
  • Created: Fri Jan 20 05:00:46 2012
  • Total Pages: 2

Absorption Pharmaceuticals to Attend Urological Conference with Its... Absorption Pharmaceuticals to Attend Urological Conference with Its GroundBreaking Treatment for Premature EjaculationAnthony Balchunas President-Elect of the Urology Association of Physician Assistants isexcited to have Absorption Pharmaceuticals participate in upcoming conference He statesHow fitting for Absorption with their...

promescent.com/sites/default/files/Attend-Urological-CO...ogical-COnf.pdf
Filing
  • Size: 54 KB
  • Author: none
  • Created: Thu Nov 1 11:27:12 2007
  • Total Pages: 8

PROGENICS Pharmaceuticals INC PROGENICS Pharmaceuticals INCFORM 8-KCurrent report filingFiled 11 01 07 for the Period Ending 11 01 07Address 777 OLD SAW MILL RIVER ROADTARRYTOWN NY 10591Telephone 9147892800CIK 0000835887Symbol PGNXSIC Code 2834 - Pharmaceutical PreparationsIndustry Biotechnology DrugsSector TechnologyFiscal Year 12 31http www edgar-online comCopyright 2007 EDGAR Online Inc All Rig...

files.shareholder.com/downloads/PGNX/0x0xS835887-07-37/...5887/filing.pdf
Merrion151009
  • Size: 139 KB
  • Author: none
  • Created: Thu Oct 15 12:37:25 2009
  • Total Pages: 2

Merrion Pharmaceuticals plc Merrion Pharmaceuticals plcMerrion or the CompanyCompletion of Placing15th October 2009Merrion Pharmaceuticals plc today announces that it has secured 600 000 from a placing of164 383 new ordinary shares of 0 01 each the Placing Shares with Enterprise Ireland ata placing price of 3 65 per Placing Share the Placing The proceeds from the Placing willbe used by Merrion to ...

merrionpharma.com/archive/Me...rrion151009.pdf
Managing Unused Pharmaceuticals Ajhpc
  • Size: 106 KB
  • Author: none
  • Created: Thu Apr 14 17:55:35 2011
  • Total Pages: 4

AJH405788 1..3 American Journal of Hospice and PalliativeMedicinehttp ajh sagepub comManaging Unused Pharmaceuticals in a Hospice Setting A Pilot StudyJoel Kreisberg and Connie ZhengAM J HOSP PALLIAT CARE published online 26 April 2011DOI 10 1177 1049909111405788The online version of this article can be found athttp ajh sagepub com content early 2011 04 26 1049909111405788Published byhttp www sage...

teleosis.org/wp-content/uploads/2012/02/Managing-Unused...icals-AJHPC.pdf
Temozolomide
  • Size: 267 KB
  • Author: none
  • Created: Tue Jun 26 08:58:39 2015
  • Total Pages: 3

Temozolomide manufacturers in India, cas. No. 85622-93-1, Active Pharmaceuticals Ingredients Temozolomide, API Manufacturer, Temozolomidebuy, sell, import, export, Temozolomide manufacturers in India cas No 85622-93-1 Active Pharmaceuticals Ingredients Temozolomide API Manufacturer Temozolomidebuy sell import export manufacturing exportTemozolomide trading India Temozolomide API Manufacturer India...

tajapi.com/pdf_3_2011/T...emozolomide.pdf
Finasteride 1mg Datasheet
  • Size: 666 KB
  • Author: none
  • Created: Fri Jul 12 13:13:06 2013
  • Total Pages: 1

Camber Pharmaceuticals Finasteride1 mgStrength NDC Size Brand Reference Brand Manufacturer Form Case Pack TE Rating Color Shape1 mg 31722-526-30 30 Propecia Merck Tab 12 AB Brown Round1 mg 31722-526-90 90 Propecia Merck Tab 12 AB Brown RoundFrom API to finished dosageCamber deliversCAMBER Pharmaceuticals INC1031 Centennial AvenuePiscataway NJ 08854Phone 732 529-0430 CamberPharma com......

camberpharma.com/datasheets/Finasteride_1mg_Datasheet.p...g_Datasheet.pdf
Prosp
  • Size: 2599 KB
  • Author: none
  • Created: Fri Jun 20 18:11:28 2014
  • Total Pages: 225

Vitae Pharmaceuticals The information in this prospectus is not complete and may be changed We may not sell these securities until the registration statement filed with the Securities and Exchange Commissionis effective This prospectus is not an offer to sell these securities and we are not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permittedSubj...

retailroadshow.com/shows/VTAE110u_rr/DP...CEUSB/prosp.pdf
111 Sheffield Pharmaceuticals
  • Size: 355 KB
  • Author: none
  • Created: Mon Feb 20 15:56:14 2012
  • Total Pages: 2

PROJECT OVERVIEW 111 Sheffield PharmaceuticalsLOCATIONNew London CTAPPLICATIONCombined heat and powerENGINE COMPRESSOR2 Waukesha L1616 GUIDISTRIBUTOR REPAdvanced Gas Engine SolutionsJoe DuffyALTRONIC PRODUCTSCPU-95 IgnitionEPC-100E AFRGSV Gas Shutoff ValveOVERVIEWSheffield Pharmaceuticals is one engine These Altronic productsof the nation s fastest growing among others provide what Altroniccontrac...

altronicinc.net/pdf/overviews/111 Sheffield Pharmaceuti...maceuticals.pdf
Ceruleanpressrelease 102408
  • Size: 18 KB
  • Author: none
  • Created: Fri Oct 24 12:40:35 2008
  • Total Pages: 2

AVEO Pharmaceuticals Secures $53 Million in Financing ContactsYates Public RelationsAdriana Jenkins617 744-1713Tempo Pharmaceuticals Inc Announces Name Change to Cerulean Pharma Inc-Company Appoints Key Senior Management Executives -Cambridge MA October 24 2008 Tempo Pharmaceuticals Inc a biopharmaceuticalcompany focused on novel intelligently designed nanoparticle-based drugs todayannounced that ...

ceruleanrx.com/Press/CeruleanPressRel...ease_102408.pdf